Evidence map›Paper›PMID 8534912›Full record

ArticleMolecular biology of the cell1995

Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.

S A Barker, K K Caldwell, A Hall, A M Martinez, J R Pfeiffer, J M Oliver, B S Wilson

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

S A BarkerDepartment of Pathology, University of New Mexico School of Medicine, Albuquerque 87131, USA.
K K Caldwell
A Hall
A M Martinez
J R Pfeiffer
J M Oliver
B S Wilson
University of New Mexico · US

Funding

WORKSHOP AT INTERNATIONAL SOCIETY FOR ANALYTICAL CYTOLOGYP41RR001315 · NCRR · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI DOORN, JONATHAN A · 1985 to 2011
$19.2M
Signaling Activity of lgE Receptor SubunitsR01GM049814 · NIGMS · UNIVERSITY OF NEW MEXICO · PI OLIVER, JANET M. · 1993 to 2008
$2.6M
NCRR NIH HHS RR-01315NIGMS NIH HHS GM-49814
6 · The paper itself

Abstract

We have investigated the effects of wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase), on antigen-mediated signaling in the RBL-2H3 mast cell model. In RBL-2H3 cells, the cross-linking of high affinity IgE receptors (Fc epsilon R1) activates at least two cytoplasmic protein tyrosine kinases, Lyn and Syk, and stimulates secretion, membrane ruffling, spreading, pinocytosis, and the formation of actin plaques implicated in increased cell-substrate adhesion. In addition, Fc epsilon R1 cross-linking activates PI 3-kinase. It was previously shown that wortmannin causes a dose-dependent inhibition of PI 3-kinase activity and also inhibits antigen-stimulated degranulation. We report that the antigen-induced synthesis of inositol(1,4,5)P3 is also markedly inhibited by wortmannin. Consistent with evidence in other cell systems implicating phosphatidylinositol(3,4,5)P3 in ruffling, pretreatment of RBL-2H3 cells with wortmannin inhibits membrane ruffling and fluid pinocytosis in response to Fc epsilon R1 cross-linking. However, wortmannin does not inhibit antigen-induced actin polymerization, receptor internalization, or the actin-dependent processes of spreading and adhesion plaque formation that follow antigen stimulation in adherent cells. Wortmannin also fails to inhibit either of the Fc epsilon R1-coupled tyrosine kinases, Lyn or Syk, or the activation of mitogen-activated protein kinase as measured by in vitro kinase assays. Strikingly, there is substantial in vitro serine/threonine kinase activity in immunoprecipitates prepared from Fc epsilon R1-activated cells using antisera to the p85 subunit of PI 3-kinase. This activity is inhibited by pretreatment of the cells with wortmannin or by the direct addition of wortmannin to the kinase assay, suggesting that PI 3-kinase itself is capable of acting as a protein kinase. We conclude that Fc epsilon R1 cross-linking activates both lipid and protein kinase activities of PI 3-kinase and that inhibiting these activities with wortmannin results in the selective block of a subset of Fc epsilon R1-mediated signaling responses.

Indexed as

Receptor AggregationActinsAndrostadienesAnimalsAntigensCell MembraneEnzyme ActivationEnzyme InhibitorsEnzyme PrecursorsInositol 1,4,5-TrisphosphateIntracellular Signaling Peptides and ProteinsLeukemia, Basophilic, AcutePhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)PinocytosisProtein Serine-Threonine KinasesActinsAndrostadienesAntigensEnzyme InhibitorsEnzyme PrecursorsInositol 1,4,5-TrisphosphateIntracellular Signaling Peptides and Proteinslyn protein-tyrosine kinasePhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine KinasesProtein-Tyrosine KinasesReceptors, IgEsrc-Family KinasesSyk KinaseSyk protein, ratWortmannin

Identifiers

PMID8534912
PMCPMC301273
OpenAlexW2161827401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.